Jerash Holdings (US) Stock Forecast, Price & News

2 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Jerash Holdings (US) in the last twelve months. There are currently 2 buy ratings for the stock. The consensus among Wall Street equities research analysts is that investors should "buy" Jerash Holdings (US) stock.
View analyst ratings for Jerash Holdings (US) or view top-rated stocks.

Wall Street analysts have given Jerash Holdings (US) a "Buy" rating, but there may be better buying opportunities in the stock market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new stock ideas, but Jerash Holdings (US) wasn't one of them. MarketBeat thinks these five companies may be even better buys.
View MarketBeat's top stock picks here.

Jerash Holdings (US) saw a increase in short interest in June. As of June 30th, there was short interest totaling 3,300 shares, an increase of 22.2% from the June 15th total of 2,700 shares. Based on an average trading volume of 17,700 shares, the days-to-cover ratio is currently 0.2 days. Currently, 0.1% of the shares of the company are sold short.
View Jerash Holdings (US)'s Short Interest.

Jerash Holdings (US) is scheduled to release its next quarterly earnings announcement on Thursday, August 12th 2021.
View our earnings forecast for Jerash Holdings (US).

Jerash Holdings (US), Inc. (NASDAQ:JRSH) announced its quarterly earnings data on Monday, June, 21st. The company reported $0.06 earnings per share (EPS) for the quarter, missing the Thomson Reuters' consensus estimate of $0.10 by $0.04. The company earned $23.76 million during the quarter. Jerash Holdings (US) had a trailing twelve-month return on equity of 7.36% and a net margin of 4.60%.
View Jerash Holdings (US)'s earnings history.

Jerash Holdings (US)'s stock was trading at $5.79 on March 11th, 2020 when Coronavirus (COVID-19) reached pandemic status according to the World Health Organization (WHO). Since then, JRSH shares have increased by 21.2% and is now trading at $7.02.
View which stocks have been most impacted by COVID-19.

Jerash Holdings (US) declared a quarterly dividend on Friday, May 14th. Stockholders of record on Tuesday, May 25th will be paid a dividend of $0.05 per share on Wednesday, June 2nd. This represents a $0.20 annualized dividend and a dividend yield of 2.85%. The ex-dividend date is Monday, May 24th.
View Jerash Holdings (US)'s dividend history.

Jerash Holdings (US) pays an annual dividend of $0.20 per share and currently has a dividend yield of 2.80%. Jerash Holdings (US) does not yet have a strong track record of dividend growth. The dividend payout ratio of Jerash Holdings (US) is 54.05%. This payout ratio is at a healthy, sustainable level, below 75%.
View Jerash Holdings (US)'s dividend history.

Jerash Holdings (US) issued an update on its FY 2022 earnings guidance on Tuesday, July, 20th. The company provided earnings per share (EPS) guidance of for the period. The company issued revenue guidance of $100 million-$102 million, compared to the consensus revenue estimate of $101 million.

2 Wall Street analysts have issued twelve-month target prices for Jerash Holdings (US)'s stock. Their forecasts range from $9.00 to $9.00. On average, they expect Jerash Holdings (US)'s share price to reach $9.00 in the next twelve months. This suggests a possible upside of 28.2% from the stock's current price.
View analysts' price targets for Jerash Holdings (US) or view top-rated stocks among Wall Street analysts.

Some companies that are related to Jerash Holdings (US) include Ever-Glory International Group (EVK), Sequential Brands Group (SQBG), Centric Brands (CTRCQ), Blue (BLHI), Panglobal Brands (PNGB), Simon Worldwide (SWWI) and Tandy Brands Accessories (TBACQ).
View all of JRSH's competitors.

Based on aggregate information from My MarketBeat watchlists, some companies that other Jerash Holdings (US) investors own include Pfizer (PFE), (PRMW), AbbVie (ABBV), Ampio Pharmaceuticals (AMPE), Applied DNA Sciences (APDN), Brainstorm Cell Therapeutics (BCLI), Bionano Genomics (BNGO), ChromaDex (CDXC), Chimerix (CMRX) and Cinemark (CNK).

Jerash Holdings (US) trades on the NASDAQ under the ticker symbol "JRSH."

Shares of JRSH can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

One share of JRSH stock can currently be purchased for approximately $7.02.

Jerash Holdings (US) has a market capitalization of $79.54 million and generates $90.21 million in revenue each year. The company earns $4.15 million in net income (profit) each year or $0.37 on an earnings per share basis.

Jerash Holdings (US) employs 4,350 workers across the globe.

The official website for Jerash Holdings (US) is www.jerashholdings.com.

Jerash Holdings (US) is headquartered at 260 EAST MAIN STREET SUITE 2706, ROCHESTER NY, 14604.

Jerash Holdings (US)'s mailing address is 260 EAST MAIN STREET SUITE 2706, ROCHESTER NY, 14604. The company can be reached via phone at 214-906-0065 or via email at [email protected]